Accustem Sciences Inc.
Data quality: 83%
ACUT
OTC
Manufacturing
Chemicals
$0.27
▼
$0.02
(-5.36%)
Mkt Cap: 4.26 M
Price
$0.27
Mkt Cap
4.26 M
Day Range
$0.27 — $0.27
52-Week Range
$0.27 — $2.33
Volume
300
Open $0.27
50D / 200D Avg
$0.48
44.28% below
50D / 200D Avg
$1.01
73.68% below
Quick Summary
Key Takeaways
Negative free cash flow of -872,332.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.35
Interest CoverageN/A
Valuation
PE (TTM)
-2.64
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -2.6 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -1.61 M |
| ROE | N/A | ROA | -101.28% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -872,332.0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.35 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -2.91 M | Tangible Book Value | -2.91 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.64 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -20.48% | ||
| Market Cap | 4.26 M | Enterprise Value | 4.26 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.11 | Revenue / Share | N/A |
| FCF / Share | -0.05 | OCF / Share | -0.05 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 54.05% |
| SBC-Adj. FCF | -956,200 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | — | — | — |
| Net Income | -1.51 M | -2.05 M | -3.75 M |
| EPS (Diluted) | -0.13 | -0.18 | — |
| Gross Profit | — | — | — |
| Operating Income | -1.51 M | -2.05 M | -3.75 M |
| EBITDA | — | — | — |
| R&D Expenses | 138,324.0 | 139,663.0 | 266,933.0 |
| SG&A Expenses | — | — | — |
| D&A | — | — | — |
| Interest Expense | — | — | — |
| Income Tax | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 50,851.0 | 133,897.0 | 939,689.0 |
| Total Liabilities | 3.36 M | 2.25 M | 1.08 M |
| Shareholders' Equity | -3.31 M | -2.11 M | -139,550.0 |
| Total Debt | — | — | — |
| Cash & Equivalents | — | — | — |
| Current Assets | 50,433.0 | 129,849.0 | 932,011.0 |
| Current Liabilities | 3.36 M | 2.25 M | 1.08 M |
{"event":"ticker_viewed","properties":{"ticker":"ACUT","listing_kind":"stock","pathname":"/stocks/acut","exchange":"OTC","country":"US"}}